Ensysce Biosciences, Inc. (ENSC) Financials

ENSC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 2.7 million 3.4 million
2023-09-30 3.2 million 2.1 million
2023-06-30 6.4 million 2.6 million
2023-03-31 3.9 million 4.1 million

ENSC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.8 million 628936
2023-09-30 -2.3 million 55674
2023-06-30 -3.1 million 77417
2023-03-31 -3.6 million 117133

ENSC Net Income

No data available :(

ENSC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.1 million - -
2023-09-30 1.5 million - 2732
2023-06-30 3.8 million - 10926
2023-03-31 1.4 million - 19120

ENSC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.3 million
2023-09-30 3.1 million
2023-06-30 2.3 million
2023-03-31 1.1 million

ENSC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 2.2 million 1.4 million 2
2023-09-30 - 1.9 million 1.2 million -
2023-06-30 - 1.6 million 1.1 million -
2023-03-31 - 1.8 million 1.6 million -

ENSC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 515032 3.4 million
2023-09-30 - -
2023-06-30 490472 1.6 million
2023-03-31 789635 1.8 million

ENSC

Price: $0.55

52 week price:
0.54
7.20

Earnings Per Share: -4.69 USD

P/E Ratio: -0.68

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 86482

Market Capitalization: 5.5 million

Links: